Previous close | 91.50 |
Open | 91.00 |
Bid | 90.00 x N/A |
Ask | 90.50 x N/A |
Day's range | 91.00 - 91.00 |
52-week range | 49.40 - 97.00 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
HCA (HCA) delivered earnings and revenue surprises of 6.99% and 2.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare are part of the Zacks top Analyst Blog.
Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.